BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
This is a short summary. The full story is published by Newsbreak.
Read full story at NewsbreakGrow your pharma business with targeted buyers Get Started
This is a short summary. The full story is published by Newsbreak.
Read full story at Newsbreak
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.

Zylidac Bio, a CDMO within the Zydus Lifesciences group, has partnered with Prolific Machines to scale Prolific's next-generation biologics…

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer…

FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should…
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.